1-3 of 3
Cheryl H. Baker
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Tolfenamic acid enhances pancreatic cancer cell and tumor response to radiation therapy by inhibiting survivin protein expression

Santhi Konduri, Jimmie Colon, Cheryl H. Baker, Stephen Safe, James L. Abbruzzese, Ala Abudayyeh, Md. Riyaz Basha, Maen Abdelrahim
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (3): 533–542.
https://doi.org/10.1158/1535-7163.MCT-08-0405
Published: 13 March 2009
View article titled, Tolfenamic acid enhances pancreatic cancer cell and tumor response to radiation therapy by inhibiting survivin protein expression
Open the PDF for Tolfenamic acid enhances pancreatic cancer cell and tumor response to radiation therapy by inhibiting survivin protein expression in another window
Includes: Supplementary data
Journal Articles

Expression of epidermal growth factor (EGF)/transforming growth factor-α by human lung cancer cells determines their response to EGF receptor tyrosine kinase inhibition in the lungs of mice

Wenjuan Wu, Michael S. O'Reilly, Robert R. Langley, Rachel Z. Tsan, Cheryl H. Baker, Neby Bekele, Xi Ming Tang, Amir Onn, Isaiah J. Fidler, Roy S. Herbst
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (10): 2652–2663.
https://doi.org/10.1158/1535-7163.MCT-06-0759
Published: 15 October 2007
View article titled, Expression of epidermal growth factor (EGF)/transforming growth factor-α by human lung cancer cells determines their response to EGF receptor tyrosine kinase inhibition in the lungs of mice
Open the PDF for Expression of epidermal growth factor (EGF)/transforming growth factor-α by human lung cancer cells determines their response to EGF receptor tyrosine kinase inhibition in the lungs of mice in another window
Journal Articles

AP23846, a novel and highly potent Src family kinase inhibitor, reduces vascular endothelial growth factor and interleukin-8 expression in human solid tumor cell lines and abrogates downstream angiogenic processes

Justin M. Summy, Jose G. Trevino, Donald P. Lesslie, Cheryl H. Baker, William C. Shakespeare, Yihan Wang, Raji Sundaramoorthi, Chester A. Metcalf, III, Jeffrey A. Keats, Tomi K. Sawyer, Gary E. Gallick
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2005) 4 (12): 1900–1911.
https://doi.org/10.1158/1535-7163.MCT-05-0171
Published: 22 December 2005
View article titled, AP23846, a novel and highly potent Src family kinase inhibitor, reduces vascular endothelial growth factor and interleukin-8 expression in human solid tumor cell lines and abrogates downstream angiogenic processes
Open the PDF for AP23846, a novel and highly potent Src family kinase inhibitor, reduces vascular endothelial growth factor and interleukin-8 expression in human solid tumor cell lines and abrogates downstream angiogenic processes in another window